Klotho Neurosciences announces s-KL longevity study; also closes $500K stock sale and reprices warrants

Greenland Mines Ltd

Pre-clinical study shows s-KL protein increased lifespan 20% in mice; company holds exclusive license for s-KL patents from UAB/ICREA.
Sold 4M shares for $500K ($0.125/share) in unregistered sale on June 5, 2025.
Repriced 4,515,762 public warrants to $1.35/share on June 10, 2025; other terms unchanged.
CEO focuses s-KL development on neurodegenerative diseases: ALS, Alzheimer's, Parkinson's.
Prof. Makoto Kuro-O, original Klotho discoverer, serves as scientific advisor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.